Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report

Por Bezan, Angelika, Hohla, Florian, Meissnitzer, Thomas, Greil, Richard
Publicado em 2013

Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives

Por Hohla, Florian, Winder, Thomas, Greil, Richard, Rick, Ferenc G, Block, Norman L, Schally, Andrew V
Publicado em 2014

Cytomegalovirus reactivation and its clinical impact in patients with solid tumors

Por Schlick, Konstantin, Grundbichler, Michael, Auberger, Jutta, Kern, Jan Marco, Hell, Markus, Hohla, Florian, Hopfinger, Georg, Greil, Richard
Publicado no Infect Agent Cancer (2015)

Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel

Por Buchholz, Stefan, Schally, Andrew V., Engel, Jörg B., Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L., Halmos, Gabor
Publicado em 2007

Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations

Por Buchholz, Stefan, Keller, Gunhild, Schally, Andrew V., Halmos, Gabor, Hohla, Florian, Heinrich, Elmar, Koester, Frank, Baker, Benjamin, Engel, Jörg B.
Publicado em 2006

Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt

Por Hohla, Florian, Schally, Andrew V., Kanashiro, Celia A., Buchholz, Stefan, Baker, Benjamin, Kannadka, Chandrika, Moder, Angelika, Aigner, Elmar, Datz, Christian, Halmos, Gabor
Publicado em 2007

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Por Rick, Ferenc G., Schally, Andrew V., Szalontay, Luca, Block, Norman L., Szepeshazi, Karoly, Nadji, Mehrdad, Zarandi, Marta, Hohla, Florian, Buchholz, Stefan, Seitz, Stephan
Publicado em 2012

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

Por Rick, Ferenc G., Seitz, Stephan, Schally, Andrew V., Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Buchholz, Stefan, Block, Norman L., Hohla, Florian
Publicado em 2012

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers

Por Rick, Ferenc G., Buchholz, Stefan, Schally, Andrew V., Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Aigner, Elmar, Perez, Roberto, Seitz, Stephan, Block, Norman L., Hohla, Florian
Publicado em 2012

Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel

Por Hohla, Florian, Schally, Andrew V., Szepeshazi, Karoly, Varga, Jozsef L., Buchholz, Stefan, Köster, Frank, Heinrich, Elmar, Halmos, Gabor, Rick, Ferenc G., Kannadka, Chandrika, Datz, Christian, Kanashiro, Celia A.
Publicado em 2006

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

Por Seitz, Stephan, Buchholz, Stefan, Schally, Andrew Victor, Weber, Florian, Klinkhammer-Schalke, Monika, Inwald, Elisabeth C, Perez, Roberto, Rick, Ferenc G, Szalontay, Luca, Hohla, Florian, Segerer, Sabine, Kwok, Chui Wai, Ortmann, Olaf, Engel, Jörg Bernhard
Publicado no BMC Cancer (2014)

A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

Por Suker, Mustafa, Beumer, Berend R., Sadot, Eran, Marthey, Lysiane, Faris, Jason E., Mellon, Eric A., El-Rayes, Bassel, Wang-Gillam, Andrea, Lacy, Jill, Hosein, Peter J., Moorcraft, Sing Yu, Conroy, Thierry, Hohla, Florian, Allen, Peter, Taieb, Julien, Hong, Theodore S., Shridhar, Ravi, Chau, Ian, van Eijck, Casper H., Koerkamp, Bas Groot
Publicado no Lancet Oncol (2016)